We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Revolution Medicines
RVMD
$38.7B
| $3.75M | 0.01% |
190,300
+83,100
| +78% | +$1.83M |
|
|
NGM
877
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.75M | 0.01% |
286,700
+89,700
| +46% | +$1.36M |
|
878
SPS Commerce
SPSC
$2.52B
| $3.74M | 0.01% |
30,076
-21,500
| -42% | -$2.61M |
|
879
Lennox International
LII
$18.9B
| $3.72M | 0.01% |
16,700
-6,400
| -28% | -$1.52M |
|
880
DHT Holdings
DHT
$2.99B
| $3.72M | 0.01% |
491,500
+418,800
| +576% | +$3.14M |
|
|
PING
881
DELISTED
Ping Identity Holding Corp.
PING
| $3.71M | 0.01% |
132,100
-155,100
| -54% | -$3.85M |
|
882
Alpha and Omega Semiconductor
AOSL
$873M
| $3.7M | 0.01% |
120,300
-23,200
| -16% | -$858K |
|
883
NETSCOUT
NTCT
$2.89B
| $3.7M | 0.01% |
118,100
-24,200
| -17% | -$792K |
|
884
Alector
ALEC
$168M
| $3.7M | 0.01% |
390,700
-20,600
| -5% | -$223K |
|
885
RingCentral
RNG
$4.71B
| $3.67M | 0.01% |
+91,900
| New | +$4.41M |
|
|
LADR
886
Ladder Capital
LADR
$1.25B
| $3.66M | 0.01% |
408,350
+45,500
| +13% | +$502K |
|
887
A.O. Smith
AOS
$8.76B
| $3.65M | 0.01% |
75,100
-6,200
| -8% | -$356K |
|
888
Main Street Capital
MAIN
$5.11B
| $3.64M | 0.01% |
108,254
+8,200
| +8% | +$338K |
|
889
Gibraltar Industries
ROCK
$1.4B
| $3.62M | 0.01% |
88,500
-5,700
| -6% | -$243K |
|
890
Extreme Networks
EXTR
$3.9B
| $3.62M | 0.01% |
276,614
-26,400
| -9% | -$333K |
|
891
Mercury Insurance
MCY
$6.06B
| $3.6M | 0.01% |
126,700
+113,800
| +882% | +$4.12M |
|
892
Valmont Industries
VMI
$9.32B
| $3.6M | 0.01% |
+13,400
| New | +$3.54M |
|
893
OFG Bancorp
OFG
$2.24B
| $3.59M | 0.01% |
142,700
+48,400
| +51% | +$1.31M |
|
894
Ezcorp Inc
EZPW
$1.84B
| $3.58M | 0.01% |
464,970
-22,000
| -5% | -$182K |
|
895
Medpace
MEDP
$16B
| $3.57M | 0.01% |
22,700
-5,900
| -21% | -$941K |
|
896
1-800-Flowers.com
FLWS
$251M
| $3.54M | 0.01% |
545,600
+65,000
| +14% | +$575K |
|
897
Thomson Reuters
TRI
$45.6B
| $3.53M | 0.01% |
32,681
+8,067
| +33% | +$935K |
|
898
Hope Bancorp
HOPE
$1.8B
| $3.52M | 0.01% |
278,563
+2,800
| +1% | +$40.5K |
|
899
PennantPark Floating Rate Capital
PFLT
$708M
| $3.52M | 0.01% |
366,675
-17,500
| -5% | -$210K |
|
900
Titan Machinery
TITN
$457M
| $3.52M | 0.01% |
124,366
-2,900
| -2% | -$82.2K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.